105 related articles for article (PubMed ID: 2539336)
1. Treatment of malignant ascites and pleurisy by a streptococcal preparation OK-432 with fresh frozen plasma--a mechanism of polymorphonuclear leukocyte (PMN) accumulation.
Kato H; Yamamura Y; Kin R; Tanigawa M; Sano H; Inoue M; Sugino S; Kondo M
Int J Immunopharmacol; 1989; 11(2):117-28. PubMed ID: 2539336
[TBL] [Abstract][Full Text] [Related]
2. Treatment of cancer ascites by intraperitoneal administration of a streptococcal preparation OK-432 with fresh human complement--role of complement-derived chemotactic factor to neutrophils.
Kondo M; Kato H; Yoshikawa T; Sugino S
Int J Immunopharmacol; 1986; 8(7):715-21. PubMed ID: 3536766
[TBL] [Abstract][Full Text] [Related]
3. Neutrophil-mediated tumor cell destruction in cancer ascites. II. A OK-432 attracts killer neutrophils through activation of complement C5.
Fujimura T; Torisu M
Clin Immunol Immunopathol; 1987 May; 43(2):174-84. PubMed ID: 3105938
[TBL] [Abstract][Full Text] [Related]
4. New approach to management of malignant ascites with streptococcal preparation OK-432. III. OK-432 attracts natural killer cells through a chemotactic factor released from activated neutrophils.
Hayashi Y; Torisu M
Surgery; 1990 Jan; 107(1):74-84. PubMed ID: 2404351
[TBL] [Abstract][Full Text] [Related]
5. Mechanism of polymorphonuclear leukocytes accumulation examined using inhibitors of complement and arachidonic acid cascade in rats treated with OK-432.
Kato H; Inoue M; Yamamura Y; Tanigawa M; Sano H; Sugino S; Kondo M
Nat Immun Cell Growth Regul; 1989; 8(5):290-300. PubMed ID: 2512482
[TBL] [Abstract][Full Text] [Related]
6. New approach to management of malignant ascites with a streptococcal preparation, OK-432. II. Intraperitoneal inflammatory cell-mediated tumor cell destruction.
Katano M; Torisu M
Surgery; 1983 Mar; 93(3):365-73. PubMed ID: 6600854
[TBL] [Abstract][Full Text] [Related]
7. [Intraperitoneal cavity injection of OK-432 with fresh human serum in a case of carcinomatous peritonitis--determination on the complement-derived chemotactic factor].
Kato H; Kondo Y; Tanigawa M; Kin R; Sugino S; Kondo M
Gan To Kagaku Ryoho; 1986 Oct; 13(11):3251-5. PubMed ID: 3777961
[TBL] [Abstract][Full Text] [Related]
8. Intracoronary C5a induces myocardial ischemia by mechanisms independent of the neutrophil: leukocyte filters desensitize the myocardium to C5a.
Engler RL; Roth DM; del Balzo U; Ito BR
FASEB J; 1991 Nov; 5(14):2983-91. PubMed ID: 1661246
[TBL] [Abstract][Full Text] [Related]
9. OK-432 induces production of neutrophil chemotactic factors in malignant pleural effusion.
Kataoka M; Morishita R; Hiramatsu J; Ueoka H; Nakata Y; Ohnoshi T; Kimura I; Harada M
Intern Med; 1995 May; 34(5):352-6. PubMed ID: 7647401
[TBL] [Abstract][Full Text] [Related]
10. Arachidonate metabolism by human polymorphonuclear leukocytes stimulated by N-formyl-Met-Leu-Phe or complement component C5a is independent of phospholipase activation.
Clancy RM; Dahinden CA; Hugli TE
Proc Natl Acad Sci U S A; 1983 Dec; 80(23):7200-4. PubMed ID: 6417666
[TBL] [Abstract][Full Text] [Related]
11. Neutrophil-mediated tumor cell destruction in cancer ascites.
Katano M; Torisu M
Cancer; 1982 Jul; 50(1):62-8. PubMed ID: 7083126
[TBL] [Abstract][Full Text] [Related]
12. [Antitumor activity of neutrophils induced by a nonspecific immunopotentiator OK-432. II. Experimental study using human malignant ascites].
Umemoto T; Saji S; Oonishi A; Kunii Y; Goshima H; Tachibana S; Takao H; Tanemura H; Sakata K
Nihon Gan Chiryo Gakkai Shi; 1988 Jul; 23(7):1512-7. PubMed ID: 3183459
[No Abstract] [Full Text] [Related]
13. New approach to management of malignant ascites with a streptococcal preparation, OK-432. I. Improvement of host immunity and prolongation of survival.
Torisu M; Katano M; Kimura Y; Itoh H; Takesue M
Surgery; 1983 Mar; 93(3):357-64. PubMed ID: 6187080
[No Abstract] [Full Text] [Related]
14. Thromboxane is produced in response to intracoronary infusions of complement C5a in pigs. Cyclooxygenase blockade does not reduce the myocardial ischemia and leukocyte accumulation.
Ito BR; Roth DM; Chenoweth DE; Lefer AM; Engler RL
Circ Res; 1989 Nov; 65(5):1220-32. PubMed ID: 2509096
[TBL] [Abstract][Full Text] [Related]
15. Demonstration of leukotriene B4 in the scale extracts of psoriasis and inflammatory pustular dermatoses. Correlation with leukocyte chemotactic activity and C5a anaphylatoxin.
Takematsu H; Terui T; Tagami H
Acta Derm Venereol; 1986; 66(1):6-10. PubMed ID: 2424218
[TBL] [Abstract][Full Text] [Related]
16. Polymorphonuclear leukocytes cap a derivative of wheat germ agglutinin upon stimulation with formyl peptide and C5a but not leukotriene B4.
Kurrasch R; Elfman F; Perez HD
J Immunol; 1989 Sep; 143(6):1969-73. PubMed ID: 2550548
[TBL] [Abstract][Full Text] [Related]
17. The in vivo effect of leukotriene B4 on polymorphonuclear leukocytes and the microcirculation. Comparison with activated complement (C5a des Arg) and enhancement by prostaglandin E2.
Movat HZ; Rettl C; Burrowes CE; Johnston MG
Am J Pathol; 1984 May; 115(2):233-44. PubMed ID: 6326579
[TBL] [Abstract][Full Text] [Related]
18. Advanced ovarian cancer treated by intraperitoneal immunotherapy with OK-432.
Kawagoe K; Masuda H
Jpn J Clin Oncol; 1986 Jun; 16(2):137-42. PubMed ID: 3735703
[TBL] [Abstract][Full Text] [Related]
19. Induction of inflammatory cytokines in the pleural effusion of cancer patients after the administration of an immunomodulator, OK-432: role of IL-8 for neutrophil infiltration.
Tsuchiya I; Kasahara T; Yamashita K; Ko YC; Kanazawa K; Matsushima K; Mukaida N
Cytokine; 1993 Nov; 5(6):595-603. PubMed ID: 8186372
[TBL] [Abstract][Full Text] [Related]
20. [The management of malignant ascites with a streptococcal preparation, OK-432: relation between the clinical effect and auto-tumor cell killing activity by OK-432-induced ascites-derived lymphocytes].
Katano M; Yamamoto H; Mizoguchi T; Hidaka K; Hisatsugu T; Torisu M
Gan To Kagaku Ryoho; 1987 Aug; 14(8):2464-8. PubMed ID: 3497612
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
